Enzolytics Stock Probability of Future Pink Sheet Price Finishing Under 9.5E-4
| ENZC Stock | USD 0 0.0001 11.11% |
Enzolytics |
Enzolytics Target Price Odds to finish below 9.5E-4
The tendency of Enzolytics Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.0009 or more in 90 days |
| 0 | 90 days | 0.0009 | about 6.09 |
Based on a normal probability distribution, the odds of Enzolytics to drop to $ 0.0009 or more in 90 days from now is about 6.09 (This Enzolytics probability density function shows the probability of Enzolytics Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Enzolytics price to stay between $ 0.0009 and its current price of $0.001 at the end of the 90-day period is about 1.2 .
Given the investment horizon of 90 days Enzolytics has a beta of 0.64 suggesting as returns on the market go up, Enzolytics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Enzolytics will be expected to be much smaller as well. Additionally Enzolytics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Enzolytics Price Density |
| Price |
Predictive Modules for Enzolytics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enzolytics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Enzolytics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Enzolytics is not an exception. The market had few large corrections towards the Enzolytics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Enzolytics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Enzolytics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.36 | |
β | Beta against Dow Jones | 0.64 | |
σ | Overall volatility | 0.0005 | |
Ir | Information ratio | -0.19 |
Enzolytics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Enzolytics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Enzolytics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Enzolytics generated a negative expected return over the last 90 days | |
| Enzolytics has high historical volatility and very poor performance | |
| Enzolytics has some characteristics of a very speculative penny stock | |
| Enzolytics has high likelihood to experience some financial distress in the next 2 years | |
| Enzolytics currently holds 233.12 K in liabilities. Enzolytics has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Enzolytics until it has trouble settling it off, either with new capital or with free cash flow. So, Enzolytics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Enzolytics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Enzolytics to invest in growth at high rates of return. When we think about Enzolytics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 190 K. Net Loss for the year was (57.28 K) with profit before overhead, payroll, taxes, and interest of 52.81 K. |
Enzolytics Technical Analysis
Enzolytics' future price can be derived by breaking down and analyzing its technical indicators over time. Enzolytics Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Enzolytics. In general, you should focus on analyzing Enzolytics Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Enzolytics Predictive Forecast Models
Enzolytics' time-series forecasting models is one of many Enzolytics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Enzolytics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Enzolytics
Checking the ongoing alerts about Enzolytics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Enzolytics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Enzolytics generated a negative expected return over the last 90 days | |
| Enzolytics has high historical volatility and very poor performance | |
| Enzolytics has some characteristics of a very speculative penny stock | |
| Enzolytics has high likelihood to experience some financial distress in the next 2 years | |
| Enzolytics currently holds 233.12 K in liabilities. Enzolytics has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Enzolytics until it has trouble settling it off, either with new capital or with free cash flow. So, Enzolytics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Enzolytics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Enzolytics to invest in growth at high rates of return. When we think about Enzolytics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 190 K. Net Loss for the year was (57.28 K) with profit before overhead, payroll, taxes, and interest of 52.81 K. |
Other Information on Investing in Enzolytics Pink Sheet
Enzolytics financial ratios help investors to determine whether Enzolytics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Enzolytics with respect to the benefits of owning Enzolytics security.